Free Newsletter
Raids put fakes-makers on notice
Last week's multinational effort to crack down on drug counterfeiters--operation Pangea--shows that the public safety threat raises intellectual property theft to a new level. Few stings targeting designer shoes or handbags are likely to have involved Pangea's level of international cooperation and law enforcement effort.
Government officials around the world have taken note of the huge problem, according to the Washington Post. Fake drugs are now the third-largest counterfeiting category, a $28 million market. Last year the represented just 10 percent of total seizures; the year before, 6 percent.
The raids netted 167,000 suspected illicit and counterfeit pills. Worldwide, the operation seized nearly 1,000 packages of suspected counterfeits and dismantled 72 drug web sites. Some 700 of the packages were seized in the U.S.
As we've reported, the growing problem is spawning tracking and thwarting technologies, industry groups, and industry research tracking manufacturer concern.
- read the article
Related Articles:
Africa rallies against counterfeits
France's Chirac plots anti-counterfeiting push
New drug ingredients to fight counterfeiting
New, high-tech ways to uncover fake meds
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




